iShares Dow Jones US Medical Dev. shares owned by Barclays
Quarter-by-quarter ownership of iShares Dow Jones US Medical Dev. (IHI) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in iShares Dow Jones US Medical Dev.
Tip: Access up to 7 years of quarterly data
All positions including iShares Dow Jones US Medical Dev. held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in iShares Dow Jones US Medical Dev. by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $5.4M | 102k | 53.35 |
| 2025-12-31 | $72k | 1.2k | 62.15 |
| 2025-09-30 | $193k | 3.2k | 60.08 |
| 2025-06-30 | $190k | 3.0k | 62.92 |
| 2025-03-31 | $98k | 1.6k | 61.22 |
| 2024-12-31 | $834k | 14k | 58.31 |
| 2024-09-30 | $558k | 9.4k | 59.25 |
| 2024-06-30 | $8.7M | 155k | 56.04 |
| 2024-03-31 | $21M | 364k | 58.59 |
| 2023-12-31 | $894k | 17k | 54.10 |
| 2023-09-30 | $1000k | 21k | 48.50 |
| 2023-06-30 | $440k | 7.8k | 56.61 |
| 2023-03-31 | $256k | 4.7k | 53.97 |
| 2022-12-31 | $342k | 6.5k | 52.57 |
| 2022-09-30 | $354k | 7.5k | 47.23 |
| 2022-06-30 | $526k | 10k | 50.43 |
| 2022-03-31 | $1.6M | 27k | 60.89 |
| 2021-12-31 | $1.6M | 24k | 65.85 |
| 2021-09-30 | $1.5M | 24k | 62.80 |
| 2021-06-30 | $62M | 171k | 361.04 |
| 2021-03-31 | $50M | 150k | 330.36 |
| 2020-12-31 | $49M | 150k | 327.30 |
| 2020-09-30 | $45M | 150k | 299.62 |
| 2020-06-30 | $40M | 150k | 264.77 |
| 2019-12-31 | $40M | 150k | 264.32 |
| 2019-09-30 | $37M | 150k | 247.24 |
| 2018-09-30 | $2.5M | 11k | 227.00 |
| 2018-03-31 | $1.1M | 6.0k | 185.00 |
| 2017-12-31 | $17k | 100 | 170.00 |
| 2017-09-30 | $17k | 100 | 170.00 |
| 2017-06-30 | $255k | 1.5k | 170.00 |
| 2017-03-31 | $266k | 1.8k | 150.00 |
| 2016-12-31 | $19k | 145 | 128.57 |
| 2013-06-30 | $1.5M | 20k | 78.51 |
| 2011-06-30 | $189k | 2.8k | 67.09 |
| 2011-03-31 | $152k | 2.4k | 64.35 |
Top funds holding iShares Dow Jones US Medical Dev.
View all funds holding iShares Dow Jones US Medical Dev.